Used in pharmaceutical research as a key intermediate in the synthesis of serotonin receptor modulators, particularly targeting 5-HT1A receptors. It plays a role in developing compounds for neurological disorders such as depression, anxiety, and schizophrenia. Its structure allows for high selectivity and binding affinity to specific serotonin receptor subtypes, making it valuable in optimizing drug candidates for improved efficacy and reduced side effects. Also employed in structure-activity relationship (SAR) studies to enhance pharmacokinetic properties of central nervous system agents. Its applications are currently confined to laboratory research and not yet in commercial or direct medical use.